151 related articles for article (PubMed ID: 34612014)
1. Comprehensive metabolic study of IOX4 in equine urine and plasma using liquid chromatography/electrospray ionization Q Exactive high-resolution mass spectrometer for the purpose of doping control.
Ishii H; Shibuya M; So YM; Wong JKY; Ho ENM; Kusano K; Sone Y; Kamiya T; Wakuno A; Ito H; Miyata K; Yamada M; Leung GN
Drug Test Anal; 2022 Feb; 14(2):233-251. PubMed ID: 34612014
[TBL] [Abstract][Full Text] [Related]
2. Long-term monitoring of IOX4 in horse hair and its longitudinal distribution with segmental analysis using liquid chromatography/electrospray ionization Q Exactive high-resolution mass spectrometry for the purpose of doping control.
Ishii H; Shibuya M; So YM; Wong JKY; Ho ENM; Kusano K; Sone Y; Kamiya T; Wakuno A; Ito H; Miyata K; Yamada M; Leung GN
Drug Test Anal; 2022 Jul; 14(7):1244-1254. PubMed ID: 35195358
[TBL] [Abstract][Full Text] [Related]
3. Metabolic study of GW1516 in equine urine using liquid chromatography/electrospray ionization Q-Exactive high-resolution mass spectrometry for doping control.
Ishii H; Shibuya M; Leung GN; Yamashita S; Yamada M; Kushiro A; Kasashima Y; Okada J; Kawasaki K; Kijima-Suda I
Rapid Commun Mass Spectrom; 2021 Mar; 35(5):e9028. PubMed ID: 33319421
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive metabolic study of nicotine in equine plasma and urine using liquid chromatography/high-resolution mass spectrometry for the identification of unique biomarkers for doping control.
Ishii H; Leung GN; Yamashita S; Nagata SI; Kushiro A; Sakai S; Toju K; Okada J; Kawasaki K; Kusano K; Kijima-Suda I
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Feb; 1190():123100. PubMed ID: 35032890
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic study of osilodrostat and identification of mono-hydroxylated metabolite in equine plasma for the purpose of doping control.
Ishii H; Ishikawa Y; Mizobe F; Nomura M; Yamanaka T; Tanabe S; Nagata SI; Yamada M; Leung GN
Rapid Commun Mass Spectrom; 2024 Mar; 38(5):e9695. PubMed ID: 38355879
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Study of Vadadustat and High-Resolution Mass Spectrometric Characterization of its Novel Metabolites in Equines for the Purpose of Doping Control.
Ishii H; Shibuya M; Kusano K; Sone Y; Kamiya T; Wakuno A; Ito H; Miyata K; Sato F; Kuroda T; Yamada M; Leung GN
Curr Drug Metab; 2022; 23(10):850-865. PubMed ID: 36017833
[TBL] [Abstract][Full Text] [Related]
7. Metabolic studies of hypoxia-inducible factor stabilisers IOX2, IOX3 and IOX4 (in vitro) for doping control.
Philip M; Mathew B; Karatt TK; Perwad Z; Subhahar MB; Karakka Kal AK
Drug Test Anal; 2021 Apr; 13(4):794-816. PubMed ID: 33458935
[TBL] [Abstract][Full Text] [Related]
8. Doping control analysis of GW1516 in equine plasma using liquid chromatography/electrospray ionization Q-Exactive high-resolution mass spectrometry.
Ishii H; Leung GN; Yamashita S; Yamada M; Kushiro A; Kasashima Y; Okada J; Kawasaki K; Kijima-Suda I
Rapid Commun Mass Spectrom; 2020 Dec; 34(23):e8920. PubMed ID: 32776613
[TBL] [Abstract][Full Text] [Related]
9. First evidence of the incorporation of daprodustat and other hypoxia-inducible factor stabilizers into equine hair by passive transfer based on segmental quantitative analysis.
Ishii H; Shibuya M; Kusano K; Sone Y; Kamiya T; Wakuno A; Ito H; Miyata K; Yamada M; Leung GN
J Pharm Biomed Anal; 2023 Oct; 235():115600. PubMed ID: 37516063
[TBL] [Abstract][Full Text] [Related]
10. A validated method for the quantification of IOX-2, a potent prolyl hydroxylase inhibitor in equine urine and plasma using liquid chromatography-high-resolution mass spectrometry.
Mikhail E; Siccardi E; Bawazir A; Rajesh A; Prathyush S; Al Wazani DMK; Sabeek M; John T
Drug Test Anal; 2021 Jun; 13(6):1178-1190. PubMed ID: 33533201
[TBL] [Abstract][Full Text] [Related]
11. Detection and longitudinal distribution of GW1516 and its metabolites in equine hair for doping control using liquid chromatography/high-resolution mass spectrometry.
Ishii H; Shibuya M; Leung GN; Nozawa S; Yamashita S; Yamada M; Kushiro A; Kasashima Y; Okada J; Kawasaki K; Kijima-Suda I
Rapid Commun Mass Spectrom; 2021 Apr; 35(8):e9050. PubMed ID: 33470485
[TBL] [Abstract][Full Text] [Related]
12. Doping control analysis of four JWH-250 metabolites in equine urine by liquid chromatography-tandem mass spectrometry.
You Y; Proctor RM; Vasilko ED; Robinson MA
Drug Test Anal; 2019 May; 11(5):649-658. PubMed ID: 30423218
[TBL] [Abstract][Full Text] [Related]
13. Metabolic study of androsta-1,4,6-triene-3,17-dione in horses using liquid chromatography/high resolution mass spectrometry.
Kwok WH; Leung GN; Wan TS; Curl P; Schiff PJ
J Steroid Biochem Mol Biol; 2015 Aug; 152():142-54. PubMed ID: 26031748
[TBL] [Abstract][Full Text] [Related]
14. lmplementation of the prolyl hydroxylase inhibitor Roxadustat (FG-4592) and its main metabolites into routine doping controls.
Eichner D; Van Wagoner RM; Brenner M; Chou J; Leigh S; Wright LR; Flippin LA; Martinelli M; Krug O; Schänzer W; Thevis M
Drug Test Anal; 2017 Nov; 9(11-12):1768-1778. PubMed ID: 28378453
[TBL] [Abstract][Full Text] [Related]
15. Liquid chromatography electrospray ionization tandem mass spectrometry for the detection of mesocarb abuse in horse doping.
Appolonova SA; Baranov PA; Mesonzhnik NV; Brazhnikova DO; Rodchenkov GM
Drug Test Anal; 2011 Oct; 3(10):717-23. PubMed ID: 21964865
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometric characterization of a prolyl hydroxylase inhibitor GSK1278863, its bishydroxylated metabolite, and its implementation into routine doping controls.
Thevis M; Milosovich S; Licea-Perez H; Knecht D; Cavalier T; Schänzer W
Drug Test Anal; 2016 Aug; 8(8):858-63. PubMed ID: 26361079
[TBL] [Abstract][Full Text] [Related]
17. Equine in vivo metabolite profiling of the selective androgen receptor modulator LGD-3303 for doping control.
Broberg MN; Knych H; Bondesson U; Pettersson C; Tidstedt B; Stanley S; Thevis M; Hedeland M
J Pharm Biomed Anal; 2023 Sep; 233():115468. PubMed ID: 37224728
[TBL] [Abstract][Full Text] [Related]
18. Sensitive liquid chromatographic/tandem mass spectrometric method for the determination of beclomethasone dipropionate and its metabolites in equine plasma and urine.
Guan F; Uboh C; Soma L; Hess A; Luo Y; Tsang DS
J Mass Spectrom; 2003 Aug; 38(8):823-38. PubMed ID: 12938103
[TBL] [Abstract][Full Text] [Related]
19. Comparison of sulfo-conjugated and gluco-conjugated urinary metabolites for detection of methenolone misuse in doping control by LC-HRMS, GC-MS and GC-HRMS.
Fragkaki AG; Angelis YS; Kiousi P; Georgakopoulos CG; Lyris E
J Mass Spectrom; 2015 May; 50(5):740-8. PubMed ID: 26259657
[TBL] [Abstract][Full Text] [Related]
20. Doping control analysis of antipsychotics and other prohibited substances in equine plasma by liquid chromatography/tandem mass spectrometry.
Wong ASY; Choi TLS; Kwok KY; Wong JKY; Wan TSM; Ho ENM
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Jun; 1147():122132. PubMed ID: 32417678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
